Enjoy complimentary customisation on priority with our Enterprise License!
The Insomnia Therapeutics Market size is estimated to grow by USD 1.10 billion at a CAGR of 5.72% between 2023 and 2028. The market is experiencing significant growth due to the increasing prevalence of insomnia, particularly in developed regions. The market is also witnessing an increased focus on non-pharmacological treatments, such as cognitive behavioral therapy and relaxation techniques, as alternatives to traditional medications. However, a lack of awareness of insomnia as a disease and the stigma associated with sleep disorders hinder market growth. Additionally, the development of innovative technologies, such as wearable devices and mobile applications, offers opportunities for market expansion. These trends and challenges are shaping the market, providing opportunities for companies to develop effective and accessible solutions for individuals suffering from sleep disorders.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Distribution Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.